{"id":"doi:10.1016/j.tcm.2021.12.008","kind":"review","title":"Semaglutide for the treatment of obesity","authors":["Ariana M. Chao","Jena Shaw Tronieri","Anastassia Amaro","Thomas A. Wadden"],"author_count":4,"year":2021,"published":"2021-12-21","venue":"Trends in Cardiovascular Medicine","cited_by":227,"doi":"10.1016/j.tcm.2021.12.008","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.tcm.2021.12.008","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.tcm.2021.12.008","updated":null,"pmid":"34942372","pmcid":null,"openalex_id":"W4200213833","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}